Radionuclide Drug Conjugates (RDC): A New Star in Precision Medicine 2024-02-08
In today's pharmaceutical industry, an innovative therapeutic known as "Radionuclide Drug Conjugates" (RDC) is gradually making its mark. In the 2023 FDA's approval, there is one drug called flotufolastat F-18 (Posluma). It is an intravenous binder to PSMA expressed on cells for PET imaging of prost
Read More